Pramana and ARUP Laboratories Partner to Digitize Pathology Slides and Develop AI-Powered Hematopathology Algorithms for Deployment via Edge AI
CAMBRIDGE, Mass. & SALT LAKE CITY--(BUSINESS WIRE)--Mar 11, 2025--
Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and ARUP Laboratories, the largest nonprofit clinical and academic reference laboratory in the United States, announced a collaboration to digitize pathology slides and develop AI-powered algorithms to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology. The partnership combines ARUP's hematopathology expertise with Pramana's cutting-edge SpectralHT autonomous whole-slide imaging scanners to advance diagnostic precision and efficiency.
This press release features multimedia. View the full release here:
'Hematopathology involves highly complex and difficult-to-scan specimens, where traditional methods often fall short in delivering consistent and reproducible results,' said David Ng, MD, medical director of Hematologic Flow Cytometry and Applied Artificial Intelligence at ARUP Laboratories. 'By combining our deep clinical expertise with Pramana's large-scale digitization and AI-driven analysis, we have the ability to develop and clinically validate new AI algorithms that will improve diagnostic accuracy and workflow efficiency. Additionally, this collaboration lays the foundation for the broad distribution of these AI tools, ensuring greater accessibility and impact across the pathology community.'
The AI model development process will be led by ARUP, drawing on its expert hematopathologists and annotation tools to train, refine, and validate the algorithms using real-world clinical cases and pathology slides obtained for this purpose. These algorithms will be designed and tested to run efficiently on Pramana's SpectralHT scanners, demonstrating the viability of in-line edge computing for real-time AI-powered diagnostics. ARUP and Pramana will explore commercialization strategies to enable the seamless deployment and distribution of advanced diagnostic algorithms per regulatory standards, which will run efficiently on scanners and drive broader industry adoption in clinical diagnostics.
'This collaboration with ARUP Laboratories showcases how AI-driven pathology can redefine industry standards, making diagnostics more scalable, efficient, and interoperable,' said Prasanth Perugupalli, chief product officer at Pramana. 'By leveraging edge computing, we're accelerating the adoption of advanced diagnostic algorithms, including those for complex hematopathology cases. This approach enhances precision, removes scalability barriers, and seamlessly integrates AI-driven insights into lab workflows.'
Pramana's SpectralHT scanners feature in-line Edge AI computing, allowing real-time quality control and automated image processing. This streamlined workflow reduces the burden on lab personnel while ensuring high-quality data output. The SpectralHT scanners' volumetric imaging capabilities improve image quality and detail while enhancing scanning efficiency, even for the most challenging diagnostic slides, such as microbiology, hematopathology, parasitology, and cytology.
The ongoing partnership between ARUP Laboratories and Pramana underscores a broader commitment to digitization and AI-driven pathology advancements, signaling the potential for deeper integration and expanded initiatives, including clinical applications.
About Pramana, Inc.
Pramana, Inc., an AI-powered health tech company modernizing the pathology sector, enables seamless digital adoption by pathology labs and medical centers. Built upon extensive industry experience and patented technological innovation, Pramana is a gateway for pathologists and physicians to utilize AI-enabled decision support. The company is headquartered in Cambridge, Mass., and backed by Matrix Capital, a global leader in customized investment solutions, and NTTVC, a leading firm backing diverse founders within the technology spectrum. For more information, visit www.pramana.ai.
About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the University of Utah's Spencer Fox Eccles School of Medicine and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™. ARUP is ISO 15189 and CAP accredited. For more information, visit www.aruplab.com.
Pramana:
Andrea Sampson, Sampson PR Group
[email protected]:
Bonnie Stray
KEYWORD: UNITED STATES NORTH AMERICA UTAH MASSACHUSETTS
INDUSTRY KEYWORD: RESEARCH TECHNOLOGY MEDICAL DEVICES HEALTH TECHNOLOGY SOFTWARE BIOTECHNOLOGY HEALTH SCIENCE ONCOLOGY ARTIFICIAL INTELLIGENCE
SOURCE: Pramana
Copyright Business Wire 2025.
PUB: 03/11/2025 08:10 AM/DISC: 03/11/2025 08:09 AM
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12-06-2025
- Yahoo
LAX/Metro Transit Center Station opens after completion of construction
The Los Angeles International Airport (LAX)/Metro Transit Center Station development in Los Angeles (LA), US, has opened following the completion of construction, aimed at connecting the LA Metro's C and K rail lines. The station is a key component in the city's efforts to alleviate car traffic at LAX and encourage the use of public transit over taxis, rideshares, or private vehicles. It was designed by international architecture practice Grimshaw, along with architect of record and landscape architect Gruen Associates, and engineered by Arup. The LAX/Metro Transit Center Station is a pivotal element of the Landside Access Modernization Program at LAX. Grimshaw's LA studio managing partner Andrew Byrne said: 'The Metro Transit Center Station transcends the typical function of a transit hub, emerging as a significant civic landmark and gateway to the city's transport network. 'A hub of multimodal activity, the station also exemplifies the importance of thoughtful infrastructure to accelerate the necessary shift in our cities: fostering economic vitality and equity and improving the quality of life for residents and visitors alike as Los Angeles moves towards a more sustainable and connected future.' The station, located at Aviation Boulevard and 96th Street, spans over 1,100ft and features the widest light rail platform in the Metro system, offering secure and accessible connections to various destinations across LA County. The design of the station prioritises the integration of different transit options. The design is accentuated by spacious above-grade concourses with natural light and ground-level bus bays set within a landscaped public plaza. The station's design is also stated to embrace California's coastal climate, utilising passive features such as shading, natural daylighting, and ventilation. Sustainability has been a key focus of the station, which incorporates solar photovoltaic (PV) panels, infrastructure for future electric vehicle (EV) bus charging, and is targeting Leadership in Energy and Environmental Design Gold certification. The development includes other public spaces designed to offer respite within the transit environment, with drought-tolerant native planting to increase biodiversity. Arup principal Simon Rees said: 'The LAX/Metro Transit Center Station will help relieve congestion and enable sustainable and equitable access to the airport without the need to drive into the central terminal area.' The LAX/Metro Transit Center Station is expected to significantly improve the travel experience for visitors of major upcoming cultural events, including the FIFA World Cup 2026, Super Bowl LXI, and the 2028 Olympic and Paralympic Games. "LAX/Metro Transit Center Station opens after completion of construction" was originally created and published by World Construction Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Medscape
09-06-2025
- Medscape
The Healthcare Industry's Climate Time Bomb
All stakeholders in healthcare now aim to make the sector greener, and several ongoing initiatives show that real changes are possible. Recently, the 2024 Global Report from The Lancet Countdown issued an urgent warning that human health is threatened by climate inaction. Experts have cautioned that we have reached a 'point of no return' as global warming systematically undermines public health worldwide. However, what happens when the health system itself is polluted? Data from the Ministry of Health show that the healthcare sector accounts for approximately 4.4% of net global greenhouse gas emissions, roughly 1.6 gigatons of CO 2 . What is being done about this? Sector Emissions According to a new report by Health Care Without Harm, in collaboration with Arup, 'The Health Sector's Climate Footprint: How the Health Sector Contributes to the Global Climate Crisis: Opportunities for Action,' the largest contributors are the United States (546 million metric tons of CO 2 equivalent), China (342 million metric tons of CO 2 equivalent), and the European Union (248 million metric tons of CO 2 equivalent). More than half of this footprint stems from energy consumption, such as electricity, gas, steam, and air conditioning systems, combined with operational emissions. Other significant sources included agriculture (9%, including food service in health centres and cotton cultivation for surgical gowns), pharmaceuticals, and chemicals (5%, excluding production energy transport [7%] and waste treatment [3%]). A further 1% of the health sector's global climate footprint, or nearly 4 million metric tons of emissions, is derived from anaesthetic gases (0.6%) and metered-dose inhalers (0.3%). The ECODES report 'Reduction of GHG Emissions in the Healthcare Sector Focus on Scope 3 of the Carbon Footprint' categorises emissions into three types of scopes. According to Health Care Without Harm, Scope 1 covers direct emissions from daily operations, such as burning fossil fuels for heating, cooling, and anaesthetic gases; owned vehicle exhaust; and fugitive emissions from air conditioning and cold storage systems, accounting for approximately 17% of the total. Scope 2 covers indirect emissions from the acquisition and consumption of electrical energy by healthcare facilities, including electricity, steam, refrigeration, and heating, accounting for approximately 12% of the total emissions. Scope 3, the largest category, includes the production, distribution, and disposal of goods and services consumed by the sector, such as medical supplies, medicines, equipment, and associated transport. Waste Management Several initiatives have been launched from international, national, regional, public, and private perspectives. The Global Green and Healthy Hospitals Network (GGHH) includes more than 1900 members in over 80 countries, representing approximately 70,000 hospitals. GGHH supports its members in conducting sustainability projects by providing access to a wide range of exclusive and innovative tools and resources. In May 2025, GGHH published a report on the 'Chemical recycling of plastic waste from the healthcare sector,' evaluating recycling technologies, toxic by-products, carbon footprint, and economic viability to identify the best options for healthcare plastic waste. In Spain, the AIMPLAS Technological Centre in Valencia, Spain, is engaged in circular economy and decarbonisation projects, producing biocompatible, biodegradable, injectable, and resorbable materials such as polylactic acid (PLA) and their copolymer poly(lactide-co-glycolide), poly(ε-caprolactone) — PCL — and PLA-PCL, using various technologies such as synthesis and reactive extrusion. These biopolymers offer sustainable alternatives to conventional plastics and significantly reduce non-biodegradable pollution. In 2025, Granada-based Athisa opened Spain's first sustainable healthcare waste treatment plant in Ciudad Real, Spain. One of its milestones is the management of solid cytostatic waste, which, unlike traditional incineration methods, uses advanced oxidation with an ozone-like oxidant that does not generate hazardous waste. This alternative avoids the emission of greenhouse gases and the generation of hazardous ash, which is typically deposited in specialised landfills, representing a more sustainable option than incineration. Carbon Reduction The Ministry of Health launched the National Information System on the Healthcare Carbon Footprint. This tool collects and provides data on the calculation of atmospheric greenhouse gas emissions from processes that occur in different healthcare centres during a given year. In March 2025, the Ministry resumed carbon footprint workshops on the carbon footprint in healthcare centres as part of the Strategic Health and Environment Plan. From Health #ForTheClimate (ECODES) on this key initiative for decarbonisation of the healthcare sector. In a public-private partnership, the MAPIC+s project (ECODES and GSK) aims to reduce the carbon footprint of the National Health System and drive environmental sustainability. MAPIC+s offers a roadmap for healthcare organisations by integrating sustainability into strategic plans, forming sustainability committees, replacing single-use materials, and reducing fluorinated gases, with case studies from Spain. Eli Lilly and Company and DHL Freight launched a project to reduce CO₂ emissions on international routes. By using biodiesel vehicles and carefully planning routes, they aim to lower emissions from shipments between Eli Lilly and Company's Alcobendas plant in Madrid and destinations in Belgium and the Netherlands. Anaesthetic Emissions The pharmaceutical industry is also working to reduce the environmental impact of anaesthetic gases and metered-dose inhalers. Efforts are underway to accelerate the shift to near-zero carbon propellant inhalers, with the next generation expected to be launched by 2025. However, as Carlos Almonacid, MD, vice president of the Spanish Society of Pulmonology and Thoracic Surgery, emphasised at a recent press conference, good clinical control offers both environmental and economic benefits. This leads to a reduced use of rescue inhalers, which typically have a higher carbon footprint, thereby supporting healthcare system sustainability. It also conserves healthcare resources and minimises patient travel to medical centres, thereby lowering pollution associated with transportation. These factors, in turn, strengthen the doctor-patient relationship, improve treatment adherence, and build trust in the healthcare system. In January 2025, the Ministry announced the 'Green Anaesthesia' working group; the objective is to continue advancing the sustainability of the healthcare system and to develop a document of best practices and solutions to achieve 'better anaesthesia for patients and the planet,' an estimated 2% of the National Health System's carbon footprint and approximately 10% of the direct emissions from health centres. Mónica García, MD, Minister of Health of Spain, and a public-sector anaesthesiologist for 20 years, reaffirmed her 'conviction that it is possible to reduce anaesthesia's environmental impact without compromising care quality, patient health, or professional practice. That is why we convened this working group.' Digital Health Another major step in reducing the environmental footprint is moving towards digital health. However, experts caution that the environmental impact of technologies such as artificial intelligence must also be considered. Speaking to El Medico Interactivo , Miguel Ángel Casermeiro, secretary of the Spanish Association for Environmental Impact Assessment, noted that the digital sector is expected to become one of the main consumers of energy, as shown by the rising energy demand in this field. Many data centre projects are currently underway in Spain, positioning the country as a key player in the global management of digital resources. 'This new digital health landscape must also be assessed in terms of its energy use,' he said. At the same time, Casermeiro emphasised that 'Digital health will also yield significant savings in travel and information handling — potentially reducing diagnostic tests — leading to substantial savings for the National Health System.' Similarly, Jaime del Barrio, MD, president of the Digital Health Association, told El Medico Interactivo that while 'digital health has environmental impacts throughout its life cycle, including production, transportation, operations, and end-of-life management. However, the development and implementation can have a positive effect, significantly reduce the carbon footprint, and making the healthcare sector more efficient.'
Yahoo
06-06-2025
- Yahoo
Opinion: Science is Utah's quiet engine — don't stall it with cuts to important funding
Science quietly powers Utah's prosperity. From lifesaving diagnostics at ARUP Laboratories and cutting-edge biotech startups to clean energy research at Utah State and drought-resistant crops developed through university partnerships, science is behind much of what makes life in Utah better, longer and more secure. In 2024, the National Institutes of Health (NIH) awarded over $300 million to Utah institutions. That funding supported thousands of jobs, helped launch companies, and enabled groundbreaking research in everything from cancer treatments to Alzheimer's to rare disease therapies. Public health advances that benefit every Utahn — urban or rural — almost always begin through federally funded research. But now, that progress is in jeopardy. Proposed cuts and restrictions to NIH funding could have devastating effects on Utah's research institutions and economy. The plan to slash NIH's overall budget by nearly half, coupled with a proposal to reduce the indirect cost reimbursement to universities from around 50% to 15%, would mean far less money to cover the real costs of doing science. Basics like lab space, utilities, data storage and administrative support aren't luxuries — they're the infrastructure that makes research possible. For public universities like the University of Utah and Utah State, this isn't just a budget concern. It's a structural threat. Without adequate indirect cost support, universities would either have to drastically scale back research activity or shift the financial burden to students and state taxpayers. Both options would weaken Utah's competitive edge in science and technology. The consequences would ripple far beyond campus. Utah is known for its 'Industry' motto — a title that honors the resourcefulness and hard work that built our communities. Today, that industrious spirit thrives in our biotech labs, clean tech startups and health research centers. But industries can't thrive without innovation. Utah's life sciences sector depends on a steady pipeline of NIH-supported talent and discoveries emerging from research. Companies like Recursion, Myriad Genetics and BioFire Diagnostics thrive because of academic partnerships and access to skilled graduates. Pulling funding would slow innovation and shrink the talent pool. But it's not just about economics. It's about people. NIH funding supports clinical trials that help Utah families battling cancer. It funds suicide prevention programs in our schools, mental health outreach in rural counties, and pediatric care innovations at Primary Children's Hospital (PCH). It supports research for Native American communities and families dealing with chronic conditions like diabetes and asthma. Without that funding, many of these programs would disappear. I've seen the impact of public health investment firsthand. After I tested positive for latent tuberculosis as a student, I received free weekly treatment and health monitoring through the Utah County Health Department. It was science-backed care, delivered through a local system supported by federal resources. Without that treatment, I could have developed active tuberculosis — a threat not just to me but also to others. The system worked because it was built on scientific research and proactive policy. That kind of safety net doesn't happen without sustained funding. Furthermore, my nephew, Wesley, was cared for at PCH when he was just four months old. He was diagnosed with polyarteritis nodosa, a rare autoimmune disease that causes inflammation and damage to the heart. The NIH not only funds various programs at PCH but also was crucial to backing the science that led to properly diagnosing and saving Wesley. These cuts hurt the next generation. Graduate students and early career scientists — many of whom come from Utah — rely on federal research grants to get their start. If funding dries up, so do those opportunities. We risk losing promising young minds to other careers or other countries. This is not a partisan issue. Scientific progress should never be about politics. Every Utahn benefits from the medications they take, the clean water they drink, the safe food they eat and the medical care they receive. All of these are underpinned by science. Restricting it weakens our shared safety net and quality of life. Utah is built on hard work, innovation and foresight. Cutting science funding now would undermine the very foundation that allows us to adapt, compete and care for our communities. Science works for Utah — let's keep it that way.
